Overall, plasma p‐tau 217 may have diagnostic utility in different clinical settings: lower p‐tau 217 levels in memory clinic patients may help identify CAA and AD, while higher levels in survivors of symptomatic ICH may suggest underlying vascular amyloid pathology. Here, MAPT is linked to Alzheimer disease.